Nguyen, Dinh-Huy http://orcid.org/0000-0002-7981-2751
You, Sung-Hwan
Ngo, Hien Thi-Thu
Van Nguyen, Khuynh http://orcid.org/0000-0003-4007-5448
Tran, Khang Vuong
Chu, Tan-Huy
Kim, So-young
Ha, Sang-Jun http://orcid.org/0000-0002-1192-6031
Hong, Yeongjin
Min, Jung-Joon http://orcid.org/0000-0001-6358-2798
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2020M3A9G3080282, No. 2020R1A5A2031185, 2021M3C1C3097637, 2021C300, NRF-2020M3A9G3080330)
Article History
Received: 28 June 2023
Accepted: 22 July 2024
First Online: 6 August 2024
Competing interests
: A patent for a novel DNA construct aimed at the diagnosis and treatment of cancer (KR102252939) has been registered by J.M., Y.H., and S.Y. as the inventors. In addition, a patent application for an innovative anticancer therapy using engineered bacteria expressing flagellin and pore-forming proteins (KR1020210153355) has been submitted by J.M., Y.H., S.Y., and D.N. as its inventors. CNCure Biotech, Inc. possesses exclusive licenses for these intellectual properties. This IP stands to gain financial benefits upon further validation. The remaining authors declare no competing interests.